RENK Group AG
R3NK.BE News Today: Stay Updated with the Latest RENK Group AG News in Real Time
Find R3NK.BE news now at Meyka AI. Stay informed with the latest RENK Group AG stocks updates, including price news, market analysis, and expert insights.
Lloyds Banking Group Closes 72 UK Branches in June 2026
Lloyds Banking Group closes 72 branches in June 2026 across Lloyds, Halifax and Bank of Scotland due to rising digital banking demand.
Payday Super Starts July 1: What Australian Employers Must Know
Payday Super begins July 1, 2026. Employers must pay super within seven days of wages. Minimum wage rises 6%.
Ticketek Appoints Asia GM to Expand Entertainment Ticketing, June 03
Ticketek appoints Melvin Koh as General Manager, Ticketing Asia to drive platform growth and partnerships across the region.
Tencent Jumps 10.5% on WeChat AI Agent Plans, June 03
Tencent (0700.HK) stock rises 10.5% on WeChat AI agent reports. Meyka rates it B+, suggesting limited downside from HK$481.60.
Octopus Card Hong Kong Boosts Elderly Perks on June 4, 2026
Octopus Card launches monthly elderly discounts June 4. Seniors get 25% off at Maxim’s restaurants and free MTR transfer perks with elder cards.
Police Hunt Teens Over Elizabeth Line Assault, June 02
British Transport Police seek teenagers over violent assault on Elizabeth line train to Paddington on May 10. Four passengers injured in incident.
SoftBank Commits €75bn to French AI Data Centres, June 02
SoftBank pledges €75 billion for French AI data centres, deploying 3.1 GW capacity by 2031. France secures €93 billion in foreign investment.
Florida Launches Tax Calculator as Property Tax Plan Advances, June 02
Florida’s “Save Our Homes” calculator shows how a proposed $250,000 homestead exemption could affect property taxes and local revenue.
Abivax Shares Plunge 32% Despite Positive Colitis Trial Results Amid Safety Concerns
French biotech company Abivax delivered some of the strongest ulcerative colitis trial results seen in recent years. Yet, Abivax Shares (ABVX) plunged more than 32% on June 2, 2026, as investors focused on safety concerns rather than efficacy data. The selloff came after the company released positive Phase 3 maintenance trial results for its lead…